Table 3.
Protein Model | Binding Energy, ΔG (Kcal mol−1) | Ki observed (nM/μM) |
Hydrogen Bonding | |
---|---|---|---|---|
Residues | Distance (Å) | |||
H37Rv | -9.27 | 160.26 (nM) | Gln438 | 2.9 |
Phe439 | 2.9, 3.1 | |||
His451 | 3.2 | |||
Arg454 | 2.8 | |||
Ser456 | 2.8 | |||
Arg465 | 3.5 | |||
Asn493 | 3.2 | |||
D441Aa | −6.76 | 11.06 (μM) | Gln438 | 3.2 |
Phe439 | 2.7, 2.7 | |||
Arg465 | 3.4 | |||
L458Pa | −7.11 | 6.16 (μM) | Gln438 | 2.8 |
Phe439 | 2.7, 2.8 | |||
His441 | 3.2 | |||
Arg465 | 3.3, 3.5 | |||
I1112Ma | −7.18 | 5.50 (μM) | Gln438 | 2.8 |
Phe439 | 2.6, 2.8, 3.3 | |||
Arg465 | 3.5 | |||
D441A + L458P + I1112Mb | −5.82 | 53.96 (μM) | Arg454 | 3.1, 3.1 |
Binding parameters computed based on molecular docking analysis of the crystal structure of RpoB H37Rv (PDB-5UHB) with Rifampicin by Autodock 4.2. The binding parameters were calculated for RpoB of H37Rv and VPCI591; a with individual SNV and b the three SNVs co-occurring in VPCI591